Archive for April, 2012

SIRIUS-BIOTECH ACQUIRED A NOVEL ANTI HUMAN PERIOSTIN MONOCLONAL ANTIBODY WITH INHIBITORY ACTIVITY ON TUMOR GROWTH AND ANGIOGENESIS

By : April 5, 2012

Sirius-biotech has acquired from the National Cancer Institute of Genoa a novel anti-periostin antibody, OC-20,┬áthat shows inhibitory effects on tumor growth and angiogenesis in vivo in tumor-bearing mice. OC-20 reacts with an epitope localised in the second FAS1 domain (FAS1-2) of periostin. This epitope is a new cell binding site of perostin, interacting with the […]